Vimarsana
Biggest News Aggregation in the World

Page 27 - Standard Poor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Standard Poor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Standard Poor Today - Breaking & Trending Today

Fidelity National Information Services: FIS to Modernize Real-Time Payments Infrastructure and Central Bank Digital Currencies for Countries Around the World - Vimarsana News

Fidelity National Information Services: FIS to Modernize Real-Time Payments Infrastructure and Central Bank Digital Currencies for Countries Around the World

Key facts FIS is now offering a central infrastructure payment solution through RealNet Central, which enables countries to modernize or build their own real-time payments network. Additionally

MSCI Inc.: MSCI Equity Indexes August 2022 Index Review - Vimarsana News

MSCI Inc.: MSCI Equity Indexes August 2022 Index Review

MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, announced the results of the August 2022 Quarterly Index Review for the

Fidelity National Information Services: FIS Expands Wealth Offerings in the United Kingdom with New Pension Services - Vimarsana News

Fidelity National Information Services: FIS Expands Wealth Offerings in the United Kingdom with New Pension Services

Key facts FIS has enhanced its wealth management solutions to include self-invested personal pension (SIPP) servicing in the U.K. with Quai Digital Enhancing its current infrastructure

Exelixis, Inc.: Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies - Vimarsana News

Exelixis, Inc.: Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies

Provides additional opportunity for Exelixis to further expand its biotherapeutics development pipeline by combining its tumor-specific targeting approaches with Ryvu's STING agonist technology, which

What's the impact of a Russian debt default? - Vimarsana News

What's the impact of a Russian debt default?

What's the impact of a Russian debt default?